MCB, Chemistry & NST Associate Professor Daniel Nomura and MCB & Chemistry Professor Chris Chang partner with Novartis Pharmaceuticals to identify and utilize new drug targets in the human proteome.

These new advancements in chemoproteomics could increase drug efficacy and open up new protein sites for targeted drug treatment.

Read more...

Image credit: Chemical & Engineering News